Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
A GLP-1 medication currently under investigation as an injection and tablet in phase 3 clinical trials
Instruct patients on the importance of using a new, disposable needle for each insulin injection
However, there may be exceptional circumstances where dose escalation is delayed, such as: Significant gastrointestinal side effects that have not resolved after one month Concurrent acute illness or hospitalisation Patient preference to extend the titration period under medical supervision Concerns about tolerability in frail or elderly patients Healthcare professionals should review patients after starting Rybelsus to assess tolerability, reinforce dosing instructions, and plan dose escalation
The cost per dose is higher than any supplement format
